Article content continued Last month, the company’s co-founder said it was in talks with Russia, Brazil, Chile and Saudi Arabia to conduct Phase 3 trials, which determine whether the vaccine actually protects people against COVID-19 infection. Back in Canada, “we are continuing to wait for the vaccine,” said Scott Halperin, the Dalhousie scientist heading Canada’s… Read More »
The biggest test yet of an experimental COVID-19 vaccine got underway Monday with the first of some 30,000 Americans rolling up their sleeves to receive shots created by the U.S. government as part of the all-out global race to stop the outbreak. The glimmer of hope came even as Google, in one of the gloomiest… Read More »
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19. Studies suggest it better predicts the disease than other well-known symptoms such as fever and cough, but the underlying mechanisms for loss of smell in patients with COVID-19 have been unclear. Now,… Read More »
London, July 12: As per a recent study, neurological complications of COVID-19 can include delirium (abrupt change in the brain that causes mental confusion and emotional disruption), brain inflammation, stroke, and nerve damage. The study led by the research team at University College London (UCL) and University College London Hospitals (UCLH) was published in the… Read More »
COVID-19 is having a greater impact on people of color. Here’s how one extended family struggled to get care during the pandemic. The numbers are clear: The coronavirus pandemic hits people of color harder. Black and Hispanic people are more likely to get COVID-19, need to be hospitalized for it, and are far more likely… Read More »